By Sharon AtienoKenya will introduce Lenacapavir, a twice-yearly injectable pre-exposure prophylaxis (PrEP), in January 2026.The priority will be given to 10 counties, including Nairobi, Kajiado, ...

Encouraging the use of pre-exposure prophylaxis (PrEP) depends on the way that HIV risk is communicated to subgroups that are traditionally at the highest risk. A new study found that interest in PrEP ...

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...

Women are disproportionately affected by HIV, making up nearly half of new infections globally and in India. Stigma, gender ...

Today, Seema Sahay is Head of Division of Social Behavioural Research at the Indian Council of Medical Research, National Institute of Translational Virology & AIDS Research (NARI), Pune, India.

Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...

The United States, whose deep cuts to foreign aid this year under President Trump have severely impacted Africa’s health ...

Despite the capability of antiretroviral drugs to suppress HIV to undetectable levels, some people living with the human ...

(CNN) — Democrats’ dominance in Tuesday’s elections reset expectations ahead of next year’s midterm battle for House and Senate control, reinvigorating a party that has been in the political ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. In this case report, we ...